Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT04712812
- Status
- Recruiting
Conditions
- AP4-related Hereditary Spastic Paraplegia
- Early Onset Hereditary Spastic Paraplegia
- Hereditary Spastic Paraplegia
- SPG11
- SPG15
- SPG3A
- SPG4
- SPG47
- SPG50
- SPG51
- SPG52
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 30 Years
- Healthy Volunteers
- Accepted
Study Details
The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early onset symptoms of HSP with (1) a clinical diagnosis of hereditary spastic paraplegia and (2) the presence of variants in HSP related genes and/or be a relative of a person with such a diagnosis. Currently, the treatment for this disorder is generally symptomatic and available therapies improve quality of life, but are grossly inefficient in slowing the disease progression. Access to the registry information will be limited to the study staff who are responsible for recruitment and maintenance of the registry. We hope that recruitment into the registry for studies will advance knowledge of the causes, clinical course, diagnosis, and treatment of these conditions.
Key Dates
- Start date
- Apr 27, 2020
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 700 participants (estimated)
Arms
- Arm: Proband with Hereditary Spastic ParaplegiaThe study population consists of male and female patients up to the age of 30 years old with a clinical and molecular diagnosis of hereditary spastic paraplegia and/or their family members of interest (if applicable).
Primary Outcome Measure
Establishment of disease spectrum [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Darius Ebrahimi-Fakhari, MD, PhD617-355-6388
- Nicole Battaglia, BS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Nicole Battaglia, BS Darius Ebrahimi-Fakhari, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)Recruiting · Boston Children's Hospital · Boston, Massachusetts
- Spastic Paraplegia - Centers of Excellence Research NetworkRecruiting · Boston Children's Hospital · Miami, Florida
- Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)PHASE1/PHASE2 · Not Yet Recruiting · BlackfinBio Ltd · Boston, Massachusetts
- Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)PHASE1/PHASE2 · Recruiting · Elpida Therapeutics SPC · Dallas, Texas